DUBLIN–(BUSINESS WIRE)–The “Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product (Drug Therapy, E-Cigarettes, and Nicotine Inhalers), Distribution, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
The Global Smoking Cessation & Nicotine De-Addiction Product Market size was estimated at USD 23.69 billion in 2021, USD 25.85 billion in 2022, and is projected to grow at a CAGR 9.39% to reach USD 40.60 billion by 2027.
Market Segmentation & Coverage:
This research report categorizes the Smoking Cessation & Nicotine De-Addiction Product to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Product, the market was studied across Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, and Nicotine Sublingual Tablets. The Drug Therapy is further studied across Chantix (Varenicline) and Zyban (Bupropion). The Nicotine Replacement Therapies is further studied across Nicotine Gums, Nicotine Lozenges, Nicotine Sprays, and Nicotine Transdermal Patches.
- Based on Distribution, the market was studied across Drug Store, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Colorado, Connecticut, Florida, Georgia, Illinois, Michigan, New York, Ohio, Oregon, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Smoking Cessation & Nicotine De-Addiction Product Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Market Dynamics
Drivers
- Growing Prevalence of Numerous Diseases due to Smoking Such as Respiratory Disorders and Lung Cancer
- Expanding Market Penetration of De-Addiction Products Globally
- Favorable Government Initiatives to Promote Anti-Smoking Policy and Raising Awareness on the Health Impact due to Smoking
Restraints
- Side Effects Associated with the Continued Usage of De-Addiction Products Coupled with Rise of Alternatives to Tobacco
Opportunities
- Increasing Approvals and Development of New Nicotine Replacement Products
- Significant Online Market Presence Coupled with Social and Communal Support for Smoking Cessation Products
Challenges
- Product Recalls by the Manufacturer and Companies Owing to Increasing Technical Faults and Stringent Approval Process
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Smoking Cessation & Nicotine De-Addiction Product Market, by Product
7. Smoking Cessation & Nicotine De-Addiction Product Market, by Distribution
8. Americas Smoking Cessation & Nicotine De-Addiction Product Market
9. Asia-Pacific Smoking Cessation & Nicotine De-Addiction Product Market
10. Europe, Middle East & Africa Smoking Cessation & Nicotine De-Addiction Product Market
11. Competitive Landscape
12. Company Usability Profiles
13. Appendix
Companies Mentioned
- 22nd Century Group, Inc.
- Axsome Therapeutics, Inc.
- British American Tobacco PLC
- Cipla Ltd.
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline PLC
- Imperial Tobacco Company of India Limited
- Itaconix
- Japan Tobacco Inc.
- Johnson & Johnson
- JUUL Labs Inc.
- NJOY, Inc.
- Novartis International AG
- Perrigo Company PLC
- Pfizer, Inc.
- Philip Morris International Inc.
- Takeda Pharmaceutical Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/xt8ufo
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900